Iradimed (IRMD) Assets Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.44% |
| Dec 31, 2025 | 10.63% |
| Sep 30, 2025 | 21.72% |
| Jun 30, 2025 | 18.34% |
| Mar 31, 2025 | 15.58% |
| Dec 31, 2024 | 6.70% |
| Sep 30, 2024 | 7.83% |
| Jun 30, 2024 | 10.46% |
| Mar 31, 2024 | 16.39% |
| Dec 31, 2023 | 7.77% |
| Sep 30, 2023 | 9.88% |
| Jun 30, 2023 | 7.54% |
| Mar 31, 2023 | 4.46% |
| Dec 31, 2022 | 3.18% |
| Sep 30, 2022 | 1.46% |
| Jun 30, 2022 | 0.19% |
| Mar 31, 2022 | 0.28% |
| Dec 31, 2021 | 16.62% |
| Sep 30, 2021 | 11.32% |
| Jun 30, 2021 | 9.81% |
| Mar 31, 2021 | 5.59% |
| Dec 31, 2020 | 6.50% |
| Sep 30, 2020 | 12.55% |
| Jun 30, 2020 | 21.07% |
| Mar 31, 2020 | 25.65% |
| Dec 31, 2019 | 37.75% |
| Sep 30, 2019 | 33.67% |
| Jun 30, 2019 | 32.72% |
| Mar 31, 2019 | 35.15% |
| Dec 31, 2018 | 24.17% |
| Sep 30, 2018 | 23.45% |
| Jun 30, 2018 | 16.25% |
| Mar 31, 2018 | 7.60% |
| Dec 31, 2017 | 4.89% |
| Sep 30, 2017 | 6.85% |
| Jun 30, 2017 | 13.90% |
| Mar 31, 2017 | 11.86% |
| Dec 31, 2016 | 5.53% |
| Sep 30, 2016 | 14.29% |
| Jun 30, 2016 | 12.47% |
| Mar 31, 2016 | 28.60% |
| Dec 31, 2015 | 51.20% |
| Sep 30, 2015 | 38.55% |
| Jun 30, 2015 | 189.45% |
| Dec 31, 2014 | 233.62% |